These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Tan KC; Cooper MB; Ling KL; Griffin BA; Freeman DJ; Packard CJ; Shepherd J; Hales CN; Betteridge DJ Atherosclerosis; 1995 Mar; 113(2):273-87. PubMed ID: 7605366 [TBL] [Abstract][Full Text] [Related]
43. Lipid and lipoprotein dysregulation in insulin resistant states. Avramoglu RK; Basciano H; Adeli K Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697 [TBL] [Abstract][Full Text] [Related]
44. Role of enterocytes in dyslipidemia of insulin-resistant states. Nogueira JP; Brites FD Endocrinol Nutr; 2013 Apr; 60(4):179-89. PubMed ID: 22939711 [TBL] [Abstract][Full Text] [Related]
45. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Grundy SM Clin Cornerstone; 2006; 8 Suppl 1():S21-7. PubMed ID: 16903166 [TBL] [Abstract][Full Text] [Related]
46. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975 [TBL] [Abstract][Full Text] [Related]
47. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Ginsberg HN Diabetes Care; 1991 Sep; 14(9):839-55. PubMed ID: 1959476 [TBL] [Abstract][Full Text] [Related]
48. [Lipid metabolism abnormalities in Chronic Kidney Disease]. Bianchi S; Baronti A; Cominotto R; Bigazzi R G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960010 [TBL] [Abstract][Full Text] [Related]
49. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes. Pontrelli L; Parris W; Adeli K; Cheung RC Metabolism; 2002 Mar; 51(3):334-42. PubMed ID: 11887170 [TBL] [Abstract][Full Text] [Related]
50. Impact of obesity in primary hyperlipidemias. Carmena R; Ascaso JF; Real JT Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432 [TBL] [Abstract][Full Text] [Related]
51. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Bhatnagar D; Durrington PN; Channon KM; Prais H; Mackness MI Atherosclerosis; 1993 Jan; 98(1):25-32. PubMed ID: 8457248 [TBL] [Abstract][Full Text] [Related]
53. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249 [TBL] [Abstract][Full Text] [Related]
54. The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Rett K Diabetes Obes Metab; 1999 May; 1 Suppl 1():S8-16. PubMed ID: 11220289 [TBL] [Abstract][Full Text] [Related]
55. Insulin resistance, small LDL particles, and risk for atherosclerotic disease. Toth PP Curr Vasc Pharmacol; 2014; 12(4):653-7. PubMed ID: 23627975 [TBL] [Abstract][Full Text] [Related]
56. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis. De Man FH; Cabezas MC; Van Barlingen HH; Erkelens DW; de Bruin TW Eur J Clin Invest; 1996 Feb; 26(2):89-108. PubMed ID: 8904518 [TBL] [Abstract][Full Text] [Related]
58. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Rader DJ Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517 [TBL] [Abstract][Full Text] [Related]
59. Targeting FoxO1 for hypertriglyceridemia. Kim DH; Zhang T; Ringquist S; Dong HH Curr Drug Targets; 2011 Aug; 12(9):1245-55. PubMed ID: 21443465 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl. Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]